Two decades of intensive policy controversy over the patenting of biotechnological inventions have left largely unexamined what the general public in Europe believes to be at stake. The paper presents the first European interview data with a primary focus on how members of “the silent majority” understand biotech patenting. Group discussions witness a polarization involving contrasting views of the role of patents in society; first, a libertarian view focusing on e.g. rights and merit; second, a communitarian view focusing on e.g. equality and public welfare. I suggest that these positions, which have long historical roots, are expressions of more fundamental ideas about what “Good Society” is.
Aymé, S. and Soini, S. ( 2008) "Patenting and Licensing in Genetic Testing: Recommendations of the European Society of Human Genetics," European Journal of Human Genetics16: 405-11.
4.
Borrás, S. ( 2006) "The Governance of the European Patent System: Effective and Legitimate?," Economy and Society35(4): 594-610.
5.
Caulfield, T., Einsiedel, E., Merz, J.F. and Nicol, D. ( 2006) "Trust, Patents and Public Perceptions: The Governance of Controversial Biotechnology Research," Nature Biotechnology24(11): 1352-4.
6.
Cowan, R., van der Eijk, W., Lissoni, F., Lotz, P. and Schovsbo, J. ( 2007) "Policy Options for the Improvement of the European Patent System," European Parliament. Directorate General for Internal Policies.
7.
Cragg Ross Dawson (2000) "Public Perceptions of the Collection of Human Biological Samples." London: The Wellcome Trust and Medical Research Council .
8.
Crespi, C. ( 2002) "Gene and Compound Claims: Another View" URL: http://pharmalicensing.com/public/articles/view/1031301637_3d786a05f3bd5 (accessed June 2008).
9.
Crespi, R.S. ( 1999) "The Biotechnology Patent Directive is Approved at Last! ," TIBTECH17(April): 139-42.
10.
Crichton, M. ( 2006) "This Essay Breaks the Law," New York Times op-ed contribution, 19 March.
11.
Douglas, M. ( 1978) Cultural Bias. London: Royal Anthropological Institute.
12.
Douglas, M. ( 1992) Risk and Blame: Essays in Cultural Theory. London: Routledge.
13.
Douglas, M. (1996) Thought Styles. London: SAGE.
14.
Drahos, P. and Braithwaite, J. ( 2002) Information Feudalism: Who Owns the Knowledge Economy?London: Earthscan.
15.
Earnscliffe (2005) "Patenting in the Area of Health Genetics: Report of Research Findings ." Ottawa: The Canadian Biotechnology Advisory Committee (CBAC).
16.
Einsiedel, E.F. ( 2003) "Whose Genes, Whose Safe, How Safe? Publics’ and Professionals’ Views of Biobanks." Ottawa: The Canadian Biotechnology Advisory Committee.
17.
Einsiedel, E.F. ( 2008) "Publics and Gene Patents," in E. F. Einsiedel (eds) Emerging Technologies: Hindsight and Foresight, pp. 51-63. Vancouver: The University of British Columbia Press.
Euractive.com (2008) "New Approaches to Researching Public Opinion" URL: http://www.euractiv.com/en/opinion/new-approaches-researching-public-opinion/article-168265 (accessed June 2008).
21.
European Patent Office (2007) " EPO Conference Illuminates Biotechnology from all Sides" URL: http://www.epo.org/topics/news/2007/20071109.html (accessed October 2007).
22.
Gaskell, G., Allum, N.C. and Stares, S.R. ( 2003) Europeans and Biotechnology in 2002: Eurobarometer 58.0 . Bruxelles: DG Research, European Commission.
23.
Gold, R.E. and Gallochat, A. ( 2001) "The European Biotech Directive: Past as Prologue," European Law Journal7(3): 331-66.
24.
Haddow, G., Laurie, G., Cunningham-Burley, S. and Hunter, K.G. ( 2007) "Tackling Community Concerns about Commercialisation and Genetic Research: A Modest Interdisciplinary Proposal," Social Science and Medicine64: 272-82.
25.
Harmon, S. ( 2006) "The Rules of Re-Engagement: The Use of Patent Proceedings to Influence the Regulation of Science (‘What the Salmon Does When Comes Back Downstream’)," Intellectual Property Quarterly4: 648-66.
26.
Hesse, C. ( 2002) "The Rise of Intellectual Property, 700 B.C.-A.D. 2000: An Idea in Balance," Dædalus Spring: 26-45.
27.
Hoeyer, K. ( 2002) "Conflicting Notions of Personhood in Genetic Research ," Anthropology Today18(5): 9-13.
28.
Horst, M. ( 2005) "Cloning Sensations: Mass Mediated Articulation of Social Responses to Controversial Biotechnology," Public Understanding of Science14(2): 185-200.
29.
Irwin, A. ( 2006) "The Politics of Talk," Social Studies of Science36(2): 299-320.
30.
Jasanoff, S. ( 2004) "Science and Citizenship: A New Synergy," Science and Public Policy31(2): 90-4.
31.
Kevles, D. ( 2002) "A History of Patenting Life in the United States with Comparative Attention to Europe and Canada: A Report to the European Group on Ethics in Science and New Technologies." European Commission .
32.
Koktvedgaard, M. and Schovsbo, J. ( 2005) Patentret. Copenhagen: Jurist- og økonomforbundets Forlag.
33.
Marres, N. ( 2005) "Issues Spark a Public into Being," in B. Latour and P. Weibel (eds) Making Things Public: Atmospheres of Democracy, pp. 208-17. Cambridge, MA.: ZKM/Center for Art and Media, Karlsruhe and MIT Press.
34.
Merz, J.F. and Cho, M.K. ( 2005) "What are Gene Patents and Why are People Worried about Them?," Community Genetics8(4): 203-8.
35.
Mori (2001) " Public Attitudes to Human Genetic Information" Human Genetics Commission.
36.
Nelkin, D. and Andrews, L. ( 1998) "Homo Economicus: Commercialization of Body Tissue in the Age of Biotechnology," Hastings Center Report28(5): 30-9.
37.
Nowotny, H. ( 2003) "Democratizing Expertise and Socially Robust Knowledge ," Science and Public Policy30(3): 151-6.
38.
Olesen, T. ( 2006) "In the Court of Public Opinion: Transnational Problem Construction in the HIV/AIDS Medicine Access Campaign, 1998-2001," International Sociology21(1): 5-30.
39.
Pálsson, G. and Rabinow, P. ( 2001) "The Icelandic Genome Debate," Trends in Biotechnology19(5): 166-71.
40.
Schuster, M.J., Su, H. and Blaug, S. ( 2003) "Protecting Rights to Early-stage Technology," Nature Biotechnology21(6): 701-3.
41.
Sheremeta, L., Gold, R.E. and Caulfield, T. ( 2003) "Harmonizing Commercialisation and Gene Patent Policy with Other Social Goals," in B. M. Knoppers (ed.) Populations and Genetics: Legal and Socio-ethical Perspectives, pp. 423-52. Leiden: Brill, N.H.E.J., N.V. Koninklijke, Bokhandel en Drukkerij.
42.
Thaker, S. ( 2003) "The Criticality of Non-market Strategies: The European Biotechnology Patents Directive." URL: www.kellogg.northwestern.edu (accessed August 2006).
